300 related articles for article (PubMed ID: 25416666)
41. Total renal denervation reduces sympathoexcitation to different target organs in a model of chronic kidney disease.
Veiga GL; Nishi EE; Estrela HF; Lincevicius GS; Gomes GN; Simões Sato AY; Campos RR; Bergamaschi CT
Auton Neurosci; 2017 May; 204():81-87. PubMed ID: 27932204
[TBL] [Abstract][Full Text] [Related]
42. Renal sympathetic denervation for resistant hypertension.
Froeschl M; Hadziomerovic A; Ruzicka M
Can J Cardiol; 2013 May; 29(5):636-8. PubMed ID: 23541665
[TBL] [Abstract][Full Text] [Related]
43. [Renal denervation in hypertension: when? For whom? And for whom not?].
Rump LC
Dtsch Med Wochenschr; 2012 Nov; 137(48):2495-7. PubMed ID: 23168982
[No Abstract] [Full Text] [Related]
44. Illusions of truths in the Symplicity HTN-3 trial: generic design strengths but neuroscience failings.
Esler M
J Am Soc Hypertens; 2014 Aug; 8(8):593-8. PubMed ID: 25151320
[TBL] [Abstract][Full Text] [Related]
45. Updated ESH position paper on interventional therapy of resistant hypertension.
Schmieder RE; Redon J; Grassi G; Kjeldsen SE; Mancia G; Narkiewicz K; Parati G; Ruilope L; van de Borne P; Tsioufis C;
EuroIntervention; 2013 May; 9 Suppl R():R58-66. PubMed ID: 23732157
[TBL] [Abstract][Full Text] [Related]
46. [Stress and dietary salt intake in the pathogenesis of hypertension: role of the renal and sympathetic nervous system].
Lin ST; Zou WQ; Chen J; Li P
Sheng Li Xue Bao; 1999 Feb; 51(1):7-13. PubMed ID: 11972168
[TBL] [Abstract][Full Text] [Related]
47. Charting new frontiers in interventional medicine.
Fajadet J
EuroIntervention; 2013 May; 9 Suppl R():R10-1. PubMed ID: 23732138
[No Abstract] [Full Text] [Related]
48. Hypertension in CKD: Core Curriculum 2019.
Ku E; Lee BJ; Wei J; Weir MR
Am J Kidney Dis; 2019 Jul; 74(1):120-131. PubMed ID: 30898362
[TBL] [Abstract][Full Text] [Related]
49. The sympathetic nervous system and new nonpharmacologic approaches to treating hypertension: a focus on renal denervation.
Grassi G; Seravalle G; Brambilla G; Mancia G
Can J Cardiol; 2012 May; 28(3):311-7. PubMed ID: 22244774
[TBL] [Abstract][Full Text] [Related]
50. Renal sympathetic denervation for resistant , hypertension--a novel treatment strategy.
Manakshe G; Chakravarthi C; Kiran R; Menon R; Rao BH; Kumar AS; Narasimhan C
J Assoc Physicians India; 2013 Nov; 61(11):834-6. PubMed ID: 24974501
[TBL] [Abstract][Full Text] [Related]
51. Renal sympathetic denervation in hypertension.
Doumas M; Faselis C; Papademetriou V
Curr Opin Nephrol Hypertens; 2011 Nov; 20(6):647-53. PubMed ID: 21885968
[TBL] [Abstract][Full Text] [Related]
52. Role of renal sympathetic denervation in a refractory arterial hypertension patient.
Martínez-Esteban MD; Aranda-Lara P; Muñoz J; Toledo-Rojas R; Sola-Moyano E; Torres-Rueda Á; Hernández-Marrero D
Nefrologia; 2012; 32(5):670-3. PubMed ID: 23013955
[TBL] [Abstract][Full Text] [Related]
53. [Resistant hypertension and chronic kidney disease: epidemiology and prognosis].
Seidowsky A; Massy ZA; Metzger M; Stengel B
Nephrol Ther; 2014 Jun; 10(3):137-44. PubMed ID: 24726612
[TBL] [Abstract][Full Text] [Related]
54. The double challenge of resistant hypertension and chronic kidney disease.
Rossignol P; Massy ZA; Azizi M; Bakris G; Ritz E; Covic A; Goldsmith D; Heine GH; Jager KJ; Kanbay M; Mallamaci F; Ortiz A; Vanholder R; Wiecek A; Zoccali C; London GM; Stengel B; Fouque D; ; ;
Lancet; 2015 Oct; 386(10003):1588-98. PubMed ID: 26530623
[TBL] [Abstract][Full Text] [Related]
55. [Catheter-based treatment of drug-resistant hypertension].
De Benedetti E
Rev Med Suisse; 2011 Nov; 7(317):2242-4. PubMed ID: 22400353
[TBL] [Abstract][Full Text] [Related]
56. Sympathetic nervous system influences on the kidney. Role in hypertension.
DiBona GF
Am J Hypertens; 1989 Mar; 2(3 Pt 2):119S-124S. PubMed ID: 2647102
[TBL] [Abstract][Full Text] [Related]
57. Improvement of renal function after renal sympathetic denervation in CKD patients with controlled vs. uncontrolled hypertension.
Kiuchi MG; Chen S
Int J Cardiol; 2016 Nov; 223():494-496. PubMed ID: 27544613
[No Abstract] [Full Text] [Related]
58. Renal denervation: transition from pathophysiology to clinical practice.
Gossios TD; Ziakas A; Doumas M; Katsiki N; Petroglou D; Kouparanis A; Lillis L; Karvounis H
Angiology; 2014 Oct; 65(9):760-8. PubMed ID: 24402321
[TBL] [Abstract][Full Text] [Related]
59. Sympathetic Nervous System Contributions to Hypertension: Updates and Therapeutic Relevance.
DeLalio LJ; Sved AF; Stocker SD
Can J Cardiol; 2020 May; 36(5):712-720. PubMed ID: 32389344
[TBL] [Abstract][Full Text] [Related]
60. Renal denervation in hypertension: simplicity, or complexity?
Lantelme P; Courand PY; Bricca G
Arch Cardiovasc Dis; 2014; 107(8-9):421-3. PubMed ID: 25128935
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
